Series C Financing, new publication and app note, 3D summer school.

Dear Manu

Celebratory fireworks may be the July theme in the United States and France, but InSphero's securing of CHF 20 million in Series C financing from WILD Group Management AG, is triggering pyrotechnic-worthy celebration in Schlieren, Switzerland as well.  The recently finalized investment, announced in today's press release, is being used to rapidly expand InSphero's global footprint and broaden its portfolio of novel 3D microtissues and contract research services for 3D drug safety and efficacy testing.  
read more here



Find out how to earn your InSphero Ph.3D. and win a $500 travel grant!

InSphero 3D Summer School 2015 live webinar series
July 27 -  August 07, 2015

From basic 101 classes on 3D cell culture, to advanced sessions focused on cancer biology, toxicology and more, our 2015 webinar series gathers high-quality speakers and participants from industry and academia spanning a wide range of 3D knowledge and experience.  Attend one or attend them all, there’s no cost to register or attend. 

Registration now open!
Attending 3 or more sessions?  We’ll take care of enrollment for you!

Imaging Bile Canaliculi in 3D Liver Microtissues using the Opera Phenix High Content Screening System

Discover our new Application Note developed in conjunction with PerkinElmer: 3D high content screening assay to study hepatobiliary transporter function in human liver microtissues using the Opera Phenixâ„¢ High Content Screening System. Confocal imaging and automated image analysis were used to quantify BSEP and MRP-2-mediated efflux of fluorescent substrates into bile canaliculi.

Read the Application Note

Download Application Notes
Not registered for 3D InSightâ„¢?  Click here first.

Latest Publication Explores Combinatorial Treatments for Breast Cancer in 3D Tumor Spheroids

Radiation therapy is an important part of breast cancer treatment. Sometimes, however, tumor cells become increasingly resistant to radiation therapy. In this BMC Cancer article, scientists at Helmholtz Zentrum München have developed a 3D microtissue-based phenotypic screen which, for the first time, enables them to test which chemotherapeutic drugs can re-sensitize breast cancer cells to radiation.

Read full article


InSphero Team Grows

Join us in welcoming a new member to the InSphero sales team!

Christine Evans started March 15, 2015 as Sales Support Specialist at InSphero AG in Schlieren, Switzerland.
Connect on LinkedIn

Copyright © 2015 InSphero, All rights reserved.

unsubscribe from this list    update subscription preferences